Items where authors include "Martin, K"

Export as [feed] Atom [feed] RSS
Number of items: 11.

Article

Abani, O, Abbas, A, Abbas, F et al. (6300 more authors) (2022) Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet, 399 (10325). pp. 665-676. ISSN 0140-6736

Abani, O, Abbas, A, Abbas, F et al. (4809 more authors) (2021) Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial. The Lancet, 397 (10289). pp. 2049-2059. ISSN 0140-6736

Abani, O orcid.org/0000-0003-2209-9956, Abbas, A, Abbas, F et al. (6346 more authors) (2021) Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet, 397 (10285). pp. 1637-1645. ISSN 0140-6736

Owens, D, Wright-Hughes, A, Graham, L orcid.org/0000-0003-4276-1257 et al. (11 more authors) (2020) Problem-solving therapy rather than treatment as usual for adults after self-harm: a pragmatic, feasibility, randomised controlled trial (the MIDSHIPS trial). Pilot and Feasibility Studies, 6. 119. ISSN 2055-5784

Aitken, S, Firth, HV, McRae, J et al. (280 more authors) (2019) Finding diagnostically useful patterns in quantitative phenotypic data. The American Journal of Human Genetics, 105 (5). pp. 933-946. ISSN 0002-9297

Crabb, SJ, Martin, K, Abab, J et al. (21 more authors) (2017) COAST (Cisplatin ototoxicity attenuated by aspirin trial): A phase II double-blind, randomised controlled trial to establish if aspirin reduces cisplatin induced hearing-loss. European Journal of Cancer, 87. pp. 75-83. ISSN 0959-8049

McRae, JF, Clayton, S, Fitzgerald, TW et al. (299 more authors) (2017) Prevalence and architecture of de novo mutations in developmental disorders. Nature, 542. pp. 433-438. ISSN 0028-0836

McRae, JF, Clayton, S, Fitzgerald, TW et al. (298 more authors) (2016) Prevalence, phenotype and architecture of developmental disorders caused by de novo mutation: The Deciphering Developmental Disorders Study. bioRxiv. (Submitted)

Collinson, M, Owens, DW, Blenkiron, P et al. (9 more authors) (2014) MIDSHIPS: Multicentre Intervention Designed for Self-Harm using Interpersonal Problem-Solving: protocol for a randomised controlled feasibility study. Trials, 15 (163). 1 - 7 (7). ISSN 1745-6215

Proceedings Paper

Ibrahim, MET, Clarke, E, Martin, K et al. (5 more authors) (2018) Cystic fibrosis and inflammatory arthritis requiring immunosuppression: a worrying combination? In: Annals of the Rheumatic Diseases. EULAR 2018: Annual European Congress of Rheumatology, 13-16 Jun 2018, Amsterdam, Netherlands. BMJ Publishing Group , p. 1679.

Clarke, EA, Ibrahim, M, Martin, K et al. (5 more authors) (2018) P130 Immunosuppression in cystic fibrosis: how worried should we be? In: Journal of Cystic Fibrosis 2018;17(3):S95–S96. 41ST European Cystic Fibrosis Society Conference, Belgrade, Serbia, 06-09 Jun 2018. Elsevier , S95-S96.

This list was generated on Sun Mar 24 07:19:21 2024 GMT.